- Home
- EVAC vs CATX Comparison
EVAC vs CATX Comparison
Compare EVAC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$10.18
HOLD
Current Price
$3.04
Company Overview
Basic Information| Metric | EVAC | CATX |
|---|---|---|
| Founded | 2024 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 592.7M | 497.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | EVAC | CATX |
|---|---|---|
| Price | $10.18 | $3.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | 102.1K | ★ 1.7M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $1.96 |
| 52 Week High | $10.20 | $6.16 |
Technical Indicators
Market Signals| Indicator | EVAC | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 56.67 | 35.39 |
| Support Level | $10.12 | $2.85 |
| Resistance Level | N/A | $4.27 |
| Average True Range (ATR) | 0.01 | 0.16 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 66.67 | 51.67 |
Price Performance
Historical Comparison EVAC
CATX
About EVAC EQV Ventures Acquisition Corp. II Class A Ordinary Shares
EQV Ventures Acquisition Corp II is a blank check company.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.